Do GLP-1 Medications Raise Gallstone Risk, and Are Women More Likely to Get Them?

If you are on a GLP-1 medication like semaglutide or tirzepatide and you have read the label or the forums, you have probably seen gallstones mentioned. Here is a plain-language look at why that link exists, and why it matters a little more for women.

The short answer

GLP-1 medications are associated with a somewhat higher chance of gallstones and gallbladder problems, and much of that risk appears to be tied to fast weight loss rather than the drug alone. Women already have a higher baseline risk of gallstones than men, largely because of estrogen. So for many women on GLP-1s, two risk factors are stacking: the rapid weight change these medications can produce, and the hormonal picture they were already living with. That does not mean gallstones are likely for any one person, but it is a reason to know the warning signs.

Why GLP-1s and rapid weight loss can trigger gallstones

Gallstones are hardened deposits, most often made of cholesterol, that form in the gallbladder. Two things push them along: bile that is overloaded with cholesterol, and a gallbladder that does not empty often or fully. Rapid weight loss affects both. When the body burns fat quickly, the liver moves extra cholesterol into bile, and eating less can mean the gallbladder contracts less often, so bile sits and concentrates.

That is the main reason gallstones show up in the context of any fast weight loss, including bariatric surgery and very low calorie diets, not just medications. With GLP-1 drugs specifically, the manufacturer labeling flags gallbladder problems, including gallstones, as a possible issue, and it is thought to be driven mostly by the weight loss the medications cause. GLP-1s also change how quickly the stomach empties and how the gut signals fullness, which is part of why the whole digestive rhythm shifts. If you are curious about the broader ways these medications reshape the body during quick weight loss, our piece on GLP-1s and bone loss in women covers a related theme.

Why women already carry more gallstone risk

This is the part that gets less attention. Female sex is one of the classic gallstone risk factors, and estrogen is a big reason. Estrogen tends to raise cholesterol levels in bile and can slow gallbladder emptying, which is exactly the combination that favors stone formation. That is why gallstone risk climbs with pregnancy, with estrogen-containing hormone therapy, and with some estrogen-containing contraceptives.

So a woman starting a GLP-1 is not starting from a neutral baseline. If you also use hormonal birth control or menopause hormone therapy, those add to the estrogen side of the equation. This is worth a mention to your clinician rather than a source of alarm, and it is a different issue from how these drugs interact with contraception itself, which we cover in whether GLP-1s can make your pill less effective.

Symptoms women may want to watch for

Many gallstones cause no symptoms at all and are found by accident. The ones that matter tend to announce themselves. The classic sign is a "gallbladder attack": a sudden, intense pain in the upper right or center of the belly that can spread to the right shoulder or back, sometimes with nausea or vomiting. It often comes on after a fatty meal and can last from minutes to a few hours.

Signs that deserve prompt attention include pain that lasts several hours, fever with belly pain, or yellowing of the skin or eyes. Those can point to a blocked duct or inflammation rather than a quiet stone.

What generally lowers the risk, and what to track

The general themes reputable sources point to are steady rather than crash weight loss, staying hydrated, and not skipping meals for long stretches, since regular eating helps the gallbladder empty. None of that is a prescription, and the right pace of weight change is an individual conversation with your clinician.

Where tracking helps is spotting patterns. Logging when belly pain shows up, how it relates to meals, and where you are in your cycle can turn a vague worry into something concrete you can hand to a clinician. A simple habit of noting doses and symptoms alongside your cycle makes those patterns easier to see, and a tool like PepFem is built around exactly that kind of logging. The goal is not to diagnose yourself, it is to notice early and ask better questions.